Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability.
about
Treatment of poor placentation and the prevention of associated adverse outcomes--what does the future hold?Early developmental conditioning of later health and disease: physiology or pathophysiology?The effects of pravastatin on the normal human placenta: Lessons from ex-vivo modelsPravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).Fetal in vivo continuous cardiovascular function during chronic hypoxiaPregnancy after acute coronary syndrome: a proposal for patients' management and a literature review.Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess.Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular diseaseAntenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep.Pravastatin for the prevention of preeclampsia in high-risk pregnant women.Statins and pregnancy: between supposed risks and theoretical benefits.Developmental programming of cardiovascular disease by prenatal hypoxia.The fetal brain sparing response to hypoxia: physiological mechanisms.Cardiovascular function in term fetal sheep conceived, gestated and studied in the hypobaric hypoxia of the Andean altiplano.Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy.Acute hypoxia-reoxygenation and vascular oxygen sensing in the chicken embryo.Hypoxia-induced contraction of chicken embryo mesenteric arteries: mechanisms and developmental changes.Vascular effects of aerobic exercise training in rat adult offspring exposed to hypoxia-induced intrauterine growth restriction.
P2860
Q26998662-E43D8126-E3F1-41CC-90C3-ACCDA03EF95BQ30387485-65DC3E39-6A33-42D9-8ABE-44CDB15D8FDBQ36281300-0E49D926-AA6C-4351-9040-E7AA142BFA3CQ36455584-D41E5E24-33EF-4C04-B32F-F2965A52B80BQ36632637-64226418-B5EE-4153-9850-BB6B75D8F90CQ36948486-6CE529D1-5045-49EB-9CBD-1B4B9E2019FAQ36978198-EE40AE50-3FB1-4B64-B667-3310B6BCFB0EQ37284338-A3C08F68-1285-47C3-B5B2-8982174E3E93Q37430173-0024393D-FD09-4A6F-A0AB-CAC0A98CC664Q37432893-36ADF651-A958-4B85-8D5F-7F6056FC6ECEQ38000338-0EC0B967-E0B1-40EC-9773-E9A17849D72AQ38223735-DFCA46E1-1FFA-4C73-980D-1FDA517F7562Q38614901-1418CB7E-3538-43C6-B6DB-C03032B0DF89Q46530286-C8BE41C9-1FA5-4CFA-A95B-5C08E2224E1DQ46970216-C8C496CC-13D5-4638-AB92-DE9F3F96D779Q47142957-DA2C2C7E-4E48-4AFA-8998-4EECD8D2457DQ48446749-963C95C3-CF20-4B6F-9DF8-62AD970A7CF0Q51015216-7337738A-C61D-4444-8DA3-0AA091D469C0
P2860
Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Statin treatment depresses the ...... nitric oxide bioavailability.
@en
Statin treatment depresses the ...... nitric oxide bioavailability.
@nl
type
label
Statin treatment depresses the ...... nitric oxide bioavailability.
@en
Statin treatment depresses the ...... nitric oxide bioavailability.
@nl
prefLabel
Statin treatment depresses the ...... nitric oxide bioavailability.
@en
Statin treatment depresses the ...... nitric oxide bioavailability.
@nl
P2093
P2860
P1476
Statin treatment depresses the ...... nitric oxide bioavailability.
@en
P2093
Andrew D Kane
Dino A Giussani
Emilio A Herrera
Jeremy A Hansell
P2860
P304
P356
10.1113/JPHYSIOL.2011.217968
P407
P577
2011-11-21T00:00:00Z